trending Market Intelligence /marketintelligence/en/news-insights/trending/cl_vccdbhqf3gan-tqxt6w2 content esgSubNav
In This List

CytoDyn appoints board chairman

Blog

Insight Weekly: Ukraine war impact on mining; US bank growth slowdown; cloud computing headwinds

Blog

Insight Weekly: Cryptocurrency's growth; green bond market outlook; coal investors' windfall

Blog

Global M&A By the Numbers: Q1 2022

Blog

Insight Weekly: Challenges for European banks; Japan's IPO slowdown; carmakers' supply woes


CytoDyn appoints board chairman

CytoDyn Inc. appointed Scott Kelly as board chairman.

Kelly, who has served as a member of the company's board since April 2017, succeeds Anthony Caracciolo, who will continue as a director.

Vancouver, Wash.-based CytoDyn develops humanized monoclonal antibodies to treat and prevent HIV infection.